A randomised comparison of simvastatin versus simvastatin and low cholesterol diet in the treatment of hypercholesterolaemia

International Journal of Clinical Practice

Volumn 54, Issue 2, 2000, Pages

  Thuraisingham, S ^a   Tan, K H ^a   Chong, K S ^a   Yap, S F ^a   Pasamanikam, K ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AGED; ARTICLE; ASIAN; COMPARATIVE STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FLATULENCE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; TIME;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHINA; COMBINED MODALITY THERAPY; CORONARY DISEASE; DIETARY FATS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INDIA; LIPIDS; MALAYSIA; MALE; MIDDLE AGED; SIMVASTATIN;

EID: 17144471468     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Keys A. Seven countries: a multivariate analysis of diet and coronary heart disease. Cambridge and London: Harvard University Press, 1980.
2. Khoo KL, Tan H, Sambhi JS et al. Screening for blood pressure, cholesterol and glucose during National Heart weeks 1992-1994. Med J Malaysia 1996; 51(3): 307-315.
3. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol (adult treatment panel II). Circulation 1994; 89: 1329-1445.
4. Goodman DS, Bradford RH, Brewer HB Jr et al. AHA conference report on cholesterol. Diagnosis, evaluation and treatment: current status and issues (review). Circulation 1989; 80(3): 735-738.
5. Corr LA, Oliver MF. The low fat diet is ineffective. Eur Heart J 1997; 18: 18-22.
6. Cobb M, Teitelbaum H, Breslow J. Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high-vs. low-fat diets. JAMA 1991; 265: 997-1001.
7. Hunninghake D, Evan S, Dujnove C et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med 1993; 328: 1213-1219.
8. Chisholm A, Mann J, Sutherland W et al. Dietary management of patients with familial hypercholesterolemia treated with simvastatin. Q J Med 1992; 1985: 825-831.
9. Clifton PM, Wight MB, Nestel PJ. Is fat restriction needed with HMGCoA reductase inhibitor treatment? Atherosclerosis 1992; 93: 59-70.
10. Ramsay LE, Yeo WW, Jackson PR. Dietary reduction of cholesterol concentration: time to think again. BMJ 1993; 303: 953-957.
11. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Study (4S). Lancet 1994: 344: 1383-1389.
12. Jones PH, Farmer JA, Cressman MD et al. Once-daily pravastatin in patients with hypercholesterolemia: a dose-response study. Clin Cardiol 1991; 14: 146-151.
13. Keech A, Collins R, MacMahon S et al. Three-year follow-up of the Oxford Cholesterol Study assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Eur Heart J 1994; 15(2): 255-269.
14. Holme I. Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomized trials: use of meta-analysis. Br Heart J 1993; 69: S42-S50.
15. Strandberg TE, Salomaa VV, Naukarinen VA et al. Long-term mortality after five year multifactorial primary intervention of cardiovascular diseases in middle-aged men. JAMA 1991: 266: 1225-1229.
16. Consensus Panel Statement. Preventing heart attack and death in patients with coronary disease. Circulation 1995; 92: 2-4.
17. Ulbright TLV, Southgate DAT. Coronary heart disease: seven dietary factors. Lancet 1991; 338: 985-992.
18. Briton EA, Eisenberg S, Breslow JL. A low fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest 1990; 85: 44-51.
19. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993; 87(6): 1781-1791.
20. Sacks FM, Pfeffer MA, Moye LA et al. Cholesterol and Recurrent Events trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 35: 1001-1009.
21. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95(5): 1126-1131.
22. The Pravastatin Multinational Study Group For Cardiac Risk Patients. Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/l (200 to 300 mg/dl) plus two additional artherosclerotic risk factors. Am J Cardiol 1993; 72: 1031-1037.
23. Sandset PM, Lund H, Norseth J et al. Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arterioscler Thromb 1991; 11(1): 138-145.
24. Jay RH, Rampling MW, Betteridge DJ. Abnormalities of blood rheology in familial hypercholesterolemia: effects of treatment. Atherosclerosis 1990; 85: 249-256.
25. Davi G, Averna M, Nove S et al. Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients. Atherosclerosis 1989; 79: 79-83.